Business Standard

Sun Pharma up 6% on generic application plans

Image

BS Reporter Mumbai

The scrip zoomed to a high of Rs 1,430 and finally ended at Rs 1,391, up 6% from the previous close. The counter clocked volumes of 131,422 shares as compared to 25,274 shares traded on the BSE. 
___________________________________________________

(Updated at 1448hrs)

The shares of Sun Pharma are quoting  6.78% up at Rs 1399.90 . They opened at Rs 1320.00, touched a high of Rs 1430 and a low of Rs 1298.95 during the day.

Sun Pharmaceutical Industries recently received the clearance of US Anti-Trust authorities for its open offer to acquire additional shares of Israeli-drug maker Taro Pharmaceutical. The company had filed an application for review of its open offer, launched last year, for buying additional stake in Israel-based Taro Pharmaceuticals by the US authorities on Aug. 28, 2009.

 

Besides, Sun Pharma aims to file 30 applications in the US for manufacturing and marketing its generic products.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 29 2009 | 3:48 PM IST

Explore News